The TLR4 Agonist Immunomax Affects the Phenotype of Mouse Lung Macrophages during Respiratory Syncytial Virus Infection
暂无分享,去创建一个
A. Nikonova | M. Khaitov | R. Ataullakhanov | I. Shilovskiy | A. Gaisina | A. Nikonova | R. Khaitov | M. Chulkina | A. Pichugin | E. Lebedeva | M. Khaitov | I. AtaullakhanovRavshan | Pichugin Av | M. KhaitovRakhim
[1] E. Nelson,et al. Anticancer Mechanisms in Two Murine Bone Marrow–Derived Dendritic Cell Subsets Activated with TLR4 Agonists , 2018, The Journal of Immunology.
[2] D. Logunov,et al. Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax®, as a therapeutic strategy for metastatic breast cancer , 2014, Journal of Translational Medicine.
[3] H. Perlman,et al. Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung. , 2013, American journal of respiratory cell and molecular biology.
[4] T. Wynn,et al. Obstacles and opportunities for understanding macrophage polarization , 2011, Journal of leukocyte biology.
[5] D. Postma,et al. More alternative activation of macrophages in lungs of asthmatic patients. , 2011, Journal of Allergy and Clinical Immunology.
[6] Stephen T Holgate,et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study , 2002, The Lancet.